The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Natural History of Dysplasia of the Uterine Cervix
Abstract
BACKGROUND: A historical cohort of Toronto (Ontario, Canada) women whose Pap smear histories were recorded at a major cytopathology laboratory provided the opportunity to study progression and regression of cervical dysplasia in an era (1962-1980) during which cervical squamous lesions were managed conservatively. METHODS: Actuarial and Cox's survival analyses were used to estimate the rates and relative risks of progression and regression of mild (cervical intraepithelial neoplasia 1 [CIN1]) and moderate (CIN2) dysplasias. In addition, more than 17,000 women with a history of Pap smears between 1970 and 1980 inclusive and who were diagnosed as having mild, moderate, or severe dysplasia were linked to the Ontario Cancer Registry for the outcome of any subsequent cervical cancers occurring through 1989. RESULTS: Both mild and moderate dysplasias were more likely to regress than to progress. The risk of progression from mild to severe dysplasia or worse was only 1% per year, but the risk of progression from moderate dysplasia was 16% within 2 years and 25% within 5 years. Most of the excess risk of cervical cancer for severe and moderate dysplasias occurred within 2 years of the initial dysplastic smear. After 2 years, in comparison with mild dysplasia, the relative risks for progression from severe or moderate dysplasia to cervical cancer in situ or worse was 4.2 (95% confidence interval [CI] = 3.0-5.7) and 2.5 (95% CI = 2.2-3.0), respectively. CONCLUSION: The risk of progression for moderate dysplasia was intermediate between the risks for mild and severe dysplasia; thus, the moderate category may represent a clinically useful distinction. The majority of untreated mild dysplasias were recorded as regressing to yield a normal smear within 2 years.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Toutenburg, H. (1974) · Biometrische Zeitschrift · doi:10.1002/bimj.19740160814 · Cited by 1,538
NATURAL HISTORY OF CERVICAL INTRAEPITHELIAL NEOPLASIA
RICHART, R. M. (1967) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-196712000-00002 · Cited by 1,376
Natural History of Cervical Intraepithelial Neoplasia: A Critical Review
Östör, A. G. (1993) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199304000-00018 · Cited by 1,260
The Papanicolaou Test for Cervical Cancer Detection: A Triumph and a Tragedy
Koss, L. G. (1989) · JAMA · doi:10.1001/jama.1989.03420050087046 · Cited by 645
The 1988 Bethesda System for Reporting Cervical/Vaginal Cytological Diagnoses
(1989) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1989.03430070079034 · Cited by 474
Behavior of mild cervical dysplasia during long‐term follow‐up
Nasiell, K., Roger, V, & Nasiell, M. (1987) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(87)90258-x · Cited by 312
Behavior of Mild Cervical Dysplasia During Long-Term Follow-up
NASIELL, K., ROGER, V., & NASIELL, M. (1986) · Obstetrics & Gynecology · doi:10.1097/00006250-198605000-00012 · Cited by 294
Soloman, D. (1989) · Diagnostic Cytopathology · doi:10.1002/dc.2840050318 · Cited by 289
Behavior of moderate cervical dysplasia during long-term follow-up.
Nasiell, K., NASIELL, M., & Václavínková, V. (1983) · PubMed · Cited by 217
Obstetrics & Gynecology: A Window to the Specialty
Resnik, R. (2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200310000-00002 · Cited by 201
Syrjänen, K. J., Kataja, V. V., Yliskoski, M. H., Chang, F., Syrjänen, K. J., & Saarikoski, S. (1992) · PubMed · Cited by 152
Report of a National Workshop on Screening for Cancer of the Cervix.
Miller, A. B., Anderson, G., Brisson, J., Laidlaw, J., Pitre, N. L., Malcolmson, P., Mirwaldt, P., Stuart, G., & Sullivan, W. (1991) · PubMed · Cited by 147
Self-citationManagement of women with mild and moderate cervical dyskaryosis
Flannelly, G., Anderson, D., Kitchener, H. C., Mann, E. M. F., Campbell, M., Fisher, P., Walker, F., & Templeton, A. A. (1994) · BMJ · doi:10.1136/bmj.308.6941.1399 · Cited by 143
A cohort study of cervical cancer screening in British Columbia.
Boyes, D. A., Morrison, B., Knox, E. G., Draper, G. J., & Miller, A. B. (1982) · PubMed · Cited by 120
Self-citationColposcopic assessment of the accuracy of cervical cytology screening
GILES, J. A., Hudson, E., Crow, J. C., Williams, D., & Walker, P. (1988) · BMJ · doi:10.1136/bmj.296.6629.1099 · Cited by 117
Natural history of the minimally abnormal Papanicolaou smear.
Montz, F. J., Monk, B. J., Fowler, J. M., & Nguyen, L. (1992) · PubMed · Cited by 84
The Significance of Basal-Cell Hyperactivity in Cervical Biopsies
Galvin, G. A., Jones, H. W., & LINDE, R. W. T. (1955) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(16)37837-1 · Cited by 68
Dysplasia of the uterine cervix.Incidence of regression, recurrence, and cancer
Stern, E., & Neely, P. M. (1964) · Cancer · doi:10.1002/1097-0142(196404)17:4<508::aid-cncr2820170412>3.0.co;2-s · Cited by 67
Mild cervical dyskaryosis: safety of cytological surveillance
Jones, M. H., Singer, A., Jenkins, D., Cuzick, J. M., Wolfendale, M. R., Usherwood, M. M., Jones, J. J., & Balogun-Lynch, C. (1992) · The Lancet · doi:10.1016/0140-6736(92)92031-a · Cited by 62
Natural history of precancerous and early cancerous lesions of the uterine cervix.
Luthra, U. K., Prabhakar, A. K., Seth, P., Agarwal, S. S., Murthy, N. S., Bhatnagar, P., Das, D. K., & Sharma, B. K. (1987) · PubMed · Cited by 60
Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome
Kirby, A. J., Spiegelhalter, D. J., Day, N. E., Fenton, L., Swanson, K., Mann, E. M., & Macgregor, J. E. (1992) · The Lancet · doi:10.1016/0140-6736(92)90278-b · Cited by 59
Cytologic and histologic outcome following an atypical cervical smear
Hulka, B. S. (1968) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(68)90187-7 · Cited by 53
Management of the mildly abnormal Pap smear: A conservative approach
Brown, M. S., & Phillips, G. L. (1985) · Gynecologic Oncology · doi:10.1016/0090-8258(85)90020-4 · Cited by 29
Mikhail, M. S., Merkatz, I. R., & Romney, S. L. (1992) · PubMed · Cited by 26
Dysplasia and the natural history of cervical cancer: Early results of the Toronto cohort study
Narod, S. A., Thompson, D. W., Jain, M., Wall, C., Green, L. M., & Miller, A. B. (1991) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(91)90022-6 · Cited by 20
Self-citationBiological behaviour of moderate dysplasia--a prospective study.
Murthy, N. S., Sardana, S., Narang, N., Agarwal, S., Sharma, S. B., & Das, D. K. (1996) · PubMed · Cited by 10
Cited by
Human papillomavirus and cervical cancer
Burd, E. M. (2003) · Clinical Microbiology Reviews · doi:10.1128/cmr.16.1.1-17.2003 · Cited by 2,420
Kyrgiou, M., Koliopoulos, G., Martin-Hirsch, P., Arbyn, M., Prendiville, W., & Paraskevaidis, E. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68181-6 · Cited by 1,120
The epidemiology of human papillomavirus infections
Baseman, J. G., & Koutsky, L. A. (2005) · Journal of Clinical Virology · doi:10.1016/j.jcv.2004.12.008 · Cited by 955
American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer
Saslow, D., Runowicz, C. D., Solomon, D., Moscicki, A.-B., Smith, R. A., Eyre, H. J., & Cohen, C. (2002) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.52.6.342 · Cited by 927
Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W. K., Schiffman, M., Solomon, D., Wentzensen, N., & Lawson, H. W. (2013) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3182883a34 · Cited by 922
Metadata
- Authors
- Holowaty, P., Miller, A. B., Rohan, T., & To, T.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-02-03
- Volume
- 91
- Issue
- 3
- Pages
- 252-258
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2165736952
- Cited by
- 608
- References
- 27
- FWCI
- 16.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.